Ceryx Medical Secures $15 Million | To Advance Groundbreaking Heart Failure Technology
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data.
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. The new agreement with Renault accelerates commercialization and advances Wandercraft’s global robotics footprint.
The additional investment brings Rad AI’s total Series C funding to $68 million. These partnerships reflect a shared commitment to transform care delivery for millions of patients nationwide and to scale the use of generative AI across hospitals and clinics.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330